Literature DB >> 12641318

Cerebral white matter abnormalities and lifetime cognitive change: a 67-year follow-up of the Scottish Mental Survey of 1932.

Ian J Deary1, Steven A Leaper, Alison D Murray, Roger T Staff, Lawrence J Whalley.   

Abstract

Cerebral white matter abnormalities relate to cognitive functioning in elders. We examine whether this association is (a) independent of mental ability in youth and (b) related to general and/or specific mental abilities. We retested 83 participants of the Scottish Mental Survey of 1932 on a battery of mental tests. Their brains were scanned by magnetic resonance imaging. Three independent ratings (Fazekas) were made of periventricular, and subcortical and deep white matter abnormalities. Structural equation models showed that, irrespective of brain location, white matter abnormalities contributed about 14% of cognitive function variance in old age. Some of this effect might be due to hypertension. This contribution is independent of mental function in early life and is associated with general cognitive ability.

Entities:  

Mesh:

Year:  2003        PMID: 12641318     DOI: 10.1037/0882-7974.18.1.140

Source DB:  PubMed          Journal:  Psychol Aging        ISSN: 0882-7974


  23 in total

1.  Factors impacting volumetric white matter changes following whole brain radiation therapy.

Authors:  Nicholas Szerlip; Charles Rutter; Nilam Ram; Susannah Yovino; Young Kwok; William Maggio; William F Regine
Journal:  J Neurooncol       Date:  2010-08-20       Impact factor: 4.130

2.  Quantifying the effects of normal ageing on white matter structure using unsupervised tract shape modelling.

Authors:  Mark E Bastin; Susana Muñoz Maniega; Karen J Ferguson; Laura J Brown; Joanna M Wardlaw; Alasdair M J MacLullich; Jonathan D Clayden
Journal:  Neuroimage       Date:  2010-02-17       Impact factor: 6.556

3.  Improved White Matter Cerebrovascular Reactivity after Revascularization in Patients with Steno-Occlusive Disease.

Authors:  L McKetton; L Venkatraghavan; C Rosen; D M Mandell; K Sam; O Sobczyk; J Poublanc; E Gray; A Crawley; J Duffin; J A Fisher; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-20       Impact factor: 3.825

4.  Socioeconomic status is positively correlated with frontal white matter integrity in aging.

Authors:  Nathan F Johnson; Chobok Kim; Brian T Gold
Journal:  Age (Dordr)       Date:  2012-11-18

5.  Impairment of executive cognitive control in type 2 diabetes, and its effects on health-related behavior and use of health services.

Authors:  Dinh Tran; Judith Baxter; Richard F Hamman; Jim Grigsby
Journal:  J Behav Med       Date:  2013-02-22

6.  Effects of cigarette smoking and alcohol use on neurocognition and BDNF levels in a Chinese population.

Authors:  Xiang Yang Zhang; Yun-Long Tan; Da-Chun Chen; Shu-Ping Tan; Fu-De Yang; Giovana B Zunta-Soares; Jair C Soares
Journal:  Psychopharmacology (Berl)       Date:  2015-10-30       Impact factor: 4.530

7.  Enlarged perivascular spaces are associated with cognitive function in healthy elderly men.

Authors:  A M J Maclullich; J M Wardlaw; K J Ferguson; J M Starr; J R Seckl; I J Deary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

8.  Age-related changes of gene expression in the neocortex: preliminary data on RNA-Seq of the transcriptome in three functionally distinct cortical areas.

Authors:  Oksana Yu Naumova; Dean Palejev; Natalia V Vlasova; Maria Lee; Sergei Yu Rychkov; Olga N Babich; Flora M Vaccarino; Elena L Grigorenko
Journal:  Dev Psychopathol       Date:  2012-11

9.  White matter hyperintensities and medication adherence.

Authors:  Kathleen C Insel; Sheryl L Reminger; Chao-Pin Hsiao
Journal:  Biol Res Nurs       Date:  2008-10       Impact factor: 2.522

10.  White matter hyperintensities and cognition: testing the reserve hypothesis.

Authors:  Adam M Brickman; Karen L Siedlecki; Jordan Muraskin; Jennifer J Manly; José A Luchsinger; Lok-Kin Yeung; Truman R Brown; Charles DeCarli; Yaakov Stern
Journal:  Neurobiol Aging       Date:  2009-11-18       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.